Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	1459
Country	Spain

Received	2012-12-13 09:56
Peer-Review Started	2012-12-13 18:42
To Make the First Decision	2013-01-09 15:58
Return for Revision	2013-01-10 12:38
Revised
Second Decision	2013-04-15 16:27
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2013-04-16 07:55
Articles in Press
Publication Fee Transferred
Edit the Manuscript by Language Editor	2013-04-20 19:14
Typeset the Manuscript	2013-07-26 09:54
Publish the Manuscript Online	2013-07-31 09:53

ISSN	1948-5204 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Chemotherapy for cholangiocarcinoma: An update
Manuscript Source	Invited Manuscript
All Author List	Natalia Ramírez-Merino, Santiago Ponce Aix and Hernán Cortés-Funes
Funding Agency and Grant Number
Corresponding Author	Dr. Natalia Ramírez-Merino, Department of Medical Oncology, Clinica La Luz, C/ General Rodrigo 8, 28003 Madrid, Spain. narame2@gmail.com
Key Words	Gemcitabine; Oncology; Review; Cholangiocarcinoma; Chemotherapy
Core Tip	Cholangiocarcinomas (bile duct cancers) are an heterogeneous group of malignancies arising from the epithelial cells of the intrahepatic, perihilar and extrahepatic bile ducts. Leucovorin-modulated 5-fluorouracil, capecitabine monotherapy or single agent gemcitabine are reasonable options for patients with a borderline performance status. After progression in patients with an adequate performance status, active regimens that could be considered for second line treatment include gemcitabine plus capecitabine or erlotinib plus bevacizumab.
Publish Date	2013-07-31 09:53
Citation	Ramírez-Merino N, Aix SP, Cortés-Funes H. Chemotherapy for cholangio- carcinoma: An update. World J Gastrointest Oncol 2013; 5(7): 171-176
URL	http://www.wjgnet.com/1948-5204/full/v5/i7/171.htm
DOI	http://dx.doi.org/10.4251/wjgo.v5.i7.171

Full Article (PDF)	WJGO-5-171.pdf
Manuscript File	1459-Review.doc
Answering Reviewers	1459-Answering reviewers.pdf
Copyright License Agreement	1459-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	1459-Language certificate.pdf
Peer-review Report	1459-Peer reviews.pdf
Scientific Editor Work List	1459-Scientific editor work list.doc